Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00904982 · ClinicalTrials.gov registry record · NA
Randomized Trial of Interventions to Improve Warfarin Adherence
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 268
- Enrollment target
NCT00904982: Completed NA study, sponsored by University of Pennsylvania.
NCT00904982 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 268 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00904982, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 268 participants
- Enrollment target
Study Summary
The purpose of this research study is to see if a lottery which provides the opportunity to win money, a reminder system using a "Med-eMonitor", or the combination of both might be useful in helping patients to achieve better control of their anticoagulation therapy. Selection for the arms of the study is randomized by the study computer. Some will participate in the daily lottery only, some with the reminder system only, some with the reminder system and the daily lottery, and some with neither the lottery nor the reminder system.
Interventions
- BEHAVIORAL Financial Incentive and Med-eMonitor
- DEVICE 2Med-eMonitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2009-10 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00904982
The ClinicalTrials.gov registry entry for NCT00904982 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Financial Incentive and Med-eMonitor is the first listed.
NCT00904982 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00904982 about?
NCT00904982 is a clinical study titled "Randomized Trial of Interventions to Improve Warfarin Adherence". The purpose of this research study is to see if a lottery which provides the opportunity to win money, a reminder system using a "Med-eMonitor", or the combination of both might be useful in helping patients to achieve better control of their anticoagulation therapy. Selection for the arms of the st...
What is the current status of trial NCT00904982?
This trial is currently completed. It is a NA study. The enrollment target is 268 participants. The study started on 2009-10. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00904982?
The interventions under investigation include: Financial Incentive and Med-eMonitor (BEHAVIORAL), 2Med-eMonitor (DEVICE).
Who is sponsoring clinical trial NCT00904982?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.